FDA is proposing to establish criteria FDA will use in evaluating drug products or categories of drug products that present demonstrable difficulties for compounding under each section
Position 15 (Histidine D-Phenylalanine): Incorporates another D-form amino acid to support stability and reduce enzymatic cleavage
An in vitro study (Teixeira and Rumjanek, 2014) showed that human monocytes treated with ouabain at a concentration of 100 nM produced heightened levels of early markers of monocyte activation: IL-1, TNF-, IL-10, vascular endothelial growth factor (VEGF), surface monocyte activation markers such as CD69, a transmembrane type II C-lectin receptor, and HLA-DR (Human Leukocyte AntigenDR isotype) (Ziegler et al., 1994)
Mechanistically, the CD73/A2AR signaling cascade coordinates the de novo synthesis and consumption of GSH with GSSG accumulation and concomitant mitochondrial lipid peroxidation, which links potentially to PKA/E2F1dependent fine-tuning of the ratio of GSR to GPX4
